Also, arginase II (ARG2) expressed in α-smooth muscle actin (SMA)+ TAF [46] can convert arginine in ornithine, inhibiting tumor infiltrating lymphocyte (TIL) functions; this can happen in hypoxic conditions, impairing the elimination of tumor target cells. This evidence concerns the gene SMN1 and neoplasm.